Verona Pharma’s Ohtuvayre: Strong Performance and Growth Potential Drive Buy Rating
Verona Pharma (VRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from ...
Verona Pharma price target raised to $60 from $42 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised the firm’s price target on Verona Pharma (VRNA) to $60 from $42 and keeps a Buy rating on the ...
Investing4d
Verona Pharma stock target upgraded, retains buy on Q4 results
On Tuesday, H.C. Wainwright analyst increased the price target on shares of Verona Pharma (NASDAQ:VRNA) to $60 from the previous target of $42, maintaining a Buy rating on the shares. The ...
Benzinga.com9d
Verona Pharma's Options Frenzy: What You Need to Know
Whales with a lot of money to spend have taken a noticeably bullish stance on Verona Pharma. Looking at options history for Verona Pharma VRNA we detected 14 trades. If we consider the specifics ...
ETF Daily News13d
Verona Pharma (NASDAQ:VRNA) Upgraded by Roth Capital to Strong-Buy Rating
Verona Pharma has a 12-month low of $11.39 and a 12-month high of $51.80. The company has a current ratio of 13.03, a quick ratio of 12.88 and a debt-to-equity ratio of 0.93.
Investing4d
Verona Pharma stock target upgraded, retains buy on Q4 results
On Tuesday, H.C. Wainwright analyst increased the price target on shares of Verona Pharma (NASDAQ:VRNA) to $60 from the previous target of $42, maintaining a Buy rating on the shares. The adjustment ...
Yahoo Finance1d
Verona Pharma plc (VRNA)
In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against other Billionaire Joseph Edelman’s long-term stock picks. Joseph Edelman is a renowned figure ...
Yahoo Finance4d
Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?
In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against other Billionaire Joseph Edelman’s long-term stock picks. Joseph Edelman is a renowned figure ...
ETF Daily News12d
Roth Mkm Begins Coverage on Verona Pharma (NASDAQ:VRNA)
Shares of VRNA opened at $45.20 on Friday. The company has a current ratio of 13.03, a quick ratio of 12.88 and a debt-to-equity ratio of 0.93. Verona Pharma has a 12 month low of $11.39 and a 12 ...
Yahoo8d
Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week
30,134 people played the daily Crossword recently. Can you solve it faster than others?30,134 people played the daily Crossword recently. Can you solve it faster than others? Investing $10,000 in ...
ADVFN7d
Verona Pharma to Present at Jefferies London Healthcare Conference
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company overview at the Jefferies London Healthcare Conference on ...